Rankings · Price against the business

A-graded, furthest below their high

Graded A, ranked by how far the share price sits below its 52-week high. The grade is built from the filings alone; the fall is a fact about the price, not the business.

68 companies meet this test

Figures as of November 15, 2026

#CompanyGradeBelow 52-week highP/EMarket value
1VCYTVERACYTE, INC.A+-60%15.80$2B
2NRIXNURIX THERAPEUTICS, INC.A+-44%6.73$1.7B
3CORTCORCEPT THERAPEUTICS INCA+-41%57.43$8B
4LQDALIQUIDIA CORPORATIONA-37%—$5.2B
5CAICARIS LIFE SCIENCES, INC.A-36%13.88$6.6B
6BLLNBillionToOne, Inc.A-30%114.29$5B
7ILMNIllumina, Inc.A+-30%35.63$31.3B
8ISRGIntuitive Surgical, Inc.A+-25%53.70$153.8B
9HALOHALOZYME THERAPEUTICS, INC.A+-24%25.01$11.4B
10INNVInnovAge Holding Corp.A-22%157.83$1.3B
11MDLNMedline Inc.A-21%27.58$51.9B
12AVAHAveanna Healthcare Holdings Inc.A-20%8.21$2.5B
13SYKSTRYKER CORPA+-19%32.98$117.9B
14KRYSKrystal Biotech, Inc.A+-19%41.42$9B
15IRMDIRADIMED CORPORATIONA+-18%45.64$1.1B
16CVSCVS HEALTH CorpA-18%10.38$114.3B
17PTGXPROTAGONIST THERAPEUTICS, INC.A+-17%27.80$8.5B
18AUPHAurinia Pharmaceuticals Inc.A+-16%6.87$2.1B
19ALCAlcon Inc.A-15%37.43$36.1B
20GSKGSK plcA+-15%13.56$108.9B
21ATRCAtriCure, Inc.A-13%189.47$2.9B
22ENSGENSIGN GROUP, INCA-13%28.04$11B
23OSCROscar Health, Inc.A-12%13.38$9.6B
24PENPenumbra, IncA-11%80.83$12.6B
25NBIXNEUROCRINE BIOSCIENCES, INC.A+-10%24.84$16.9B

More rankings

A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.